Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Critical Pathways × Tumor-Agnostic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 NET 1 Endocrine 1

Conditions

Interventions

pembrolizumab 95 Paclitaxel 86 Gemcitabine 84 Carboplatin 79 Surveys and Questionnaires 72 Docetaxel 61 Bevacizumab 61 Nivolumab 59 Cisplatin 59 Magnetic Resonance Spectroscopy 50 Blood Specimen Collection 50 Fluorouracil 48 Capecitabine 47 Radiotherapy 46 Irinotecan 40 Oxaliplatin 38 Erlotinib Hydrochloride 38 Biopsy 36 atezolizumab 35 Leucovorin 35 Pemetrexed 34 Cetuximab 32 Specimen Handling 31 Trastuzumab 30 Standard of Care 30 Radiosurgery 29 Ipilimumab 28 Cyclophosphamide 28 Interviews as Topic 27 olaparib 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02965794 2020-01-28

CP4GICAN

European Pathway Association

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡